Kết quả tìm kiếm - Andrea Wang‐Gillam
- Đang hiển thị 1 - 20 kết quả của 58
- Chuyển đến trang tiếp theo
-
1
-
2
Targeting RAS -mutant Cancers: Is ERK the Key? Bằng Meagan B. Ryan, Channing J. Der, Andrea Wang‐Gillam, Adrienne D. Cox
Được phát hành 2015Artigo -
3
Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome Bằng Joan How, Margaret Blattner, Susan A. Fowler, Andrea Wang‐Gillam, Suzanne E. Schindler
Được phát hành 2016Revisão -
4
-
5
Neoadjuvant Therapy of Pancreatic Cancer: The Emerging Paradigm? Bằng Kian‐Huat Lim, Eugene H. Chung, Adeel S. Khan, Dengfeng Cao, David C. Linehan, Edgar Ben‐Josef, Andrea Wang‐Gillam
Được phát hành 2012Revisão -
6
NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors Bằng Andrea Wang‐Gillam, Richard Hubner, Jens T. Siveke, Daniel D. Von Hoff, Bruce Belanger, Floris A. de Jong, Beloo Mirakhur, Li‐Tzong Chen
Được phát hành 2019Artigo -
7
Tumor–Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer Bằng Daoxiang Zhang, Lin Li, Hongmei Jiang, Qiong Li, Andrea Wang‐Gillam, Jinsheng Yu, Richard Head, Jingxia Liu, Marianna B. Ruzinova, Kian‐Huat Lim
Được phát hành 2018Artigo -
8
Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models Bằng Hongmei Jiang, Ming Xu, Lin Li, Patrick Grierson, Paarth B. Dodhiawala, Maureen Highkin, Daoxiang Zhang, Qiong Li, Andrea Wang‐Gillam, Kian‐Huat Lim
Được phát hành 2018Artigo -
9
Myeloid-Derived Suppressor Cells: General Characteristics and Relevance to Clinical Management of Pancreatic Cancer Bằng Peter S. Goedegebuure, Jonathan B. Mitchem, Matthew R. Porembka, Marcus Tan, Brian A. Belt, Andrea Wang‐Gillam, William E. Gillanders, William G. Hawkins, David C. Linehan
Được phát hành 2011Revisão -
10
Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma Bằng Daoxiang Zhang, Lin Li, Hongmei Jiang, Brett L. Knolhoff, A. Craig Lockhart, Andrea Wang‐Gillam, David G. DeNardo, Marianna B. Ruzinova, Kian‐Huat Lim
Được phát hành 2016Artigo -
11
Population Pharmacokinetics of Fruquintinib, a Selective Oral Inhibitor of VEGFR ‐1, ‐2, and ‐3, in Patients with Refractory Metastatic Colorectal Cancer Bằng Xiaofei Zhou, Xiaoyan Yang, Boris Grinshpun, Adekemi Taylor, Laura E. Strong, Arvind Dasari, Andrea Wang‐Gillam, Jin Li, Rui‐Hua Xu, Neeraj Gupta, Caly Chien
Được phát hành 2025Artigo -
12
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models Bằng Yu Zhu, Brett L. Knolhoff, Melissa A. Meyer, Timothy M. Nywening, Brian L. West, Jingqin Luo, Andrea Wang‐Gillam, S. Peter Goedegebuure, David C. Linehan, David G. DeNardo
Được phát hành 2014Artigo -
13
Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation Bằng Comron Hassanzadeh, Soumon Rudra, A. Bommireddy, William G. Hawkins, Andrea Wang‐Gillam, Ryan C. Fields, Bin Cai, Justin Park, Olga Green, Michael Roach, Lauren E. Henke, Hyun Kim
Được phát hành 2020Artigo -
14
A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tum... Bằng Manik Amin, Susan Minton, Patricia LoRusso, Smitha Krishnamurthi, Cheryl A. Pickett, Jared Lunceford, Darcy A. Hille, David Mauro, Mark N. Stein, Andrea Wang‐Gillam, Lauren Trull, A. Craig Lockhart
Được phát hành 2015Artigo -
15
CA19-9 decrease and overall survival (OS) in the NAPOLI-1 trial of liposomal irinotecan (nal-IRI) ± 5-fluorouracil and leucovorin (5-FU/LV) in metastatic pancreatic ductal adenocar... Bằng L-T. Chen, Andrea Wang‐Gillam, Y-S Shan, T. Macarulla Mercadé, Jan Blanc, Richard Hubner, C-F. Chiu, G. Schwartsmann, J. Siveke, Bruce Belanger, F. de Jong, K. Mamlouk, D. Von Hoff
Được phát hành 2017Artigo -
16
A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma Bằng Andrea Wang‐Gillam, Stacey M. Plambeck-Suess, Peter S. Goedegebuure, Peter O. Simon, Jonathan B. Mitchem, John R. Hornick, Steven Sorscher, Joel Picus, Rama Suresh, A. Craig Lockhart, Benjamin Tan, W. Hawkins
Được phát hành 2012Artigo -
17
Safety and Pharmacokinetics of CXCR4 Peptide Antagonist, LY2510924, in Combination with Durvalumab in Advanced Refractory Solid Tumors Bằng Mark H. O’Hara, Wells A. Messersmith, Hedy L. Kindler, Wei Zhang, Celine Pitou, Anna M. Szpurka, Dan Wang, Sheng-Bin Peng, Burkhard Vangerow, Anis A. Khan, Mythili Koneru, Andrea Wang‐Gillam
Được phát hành 2020Artigo -
18
-
19
Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma Bằng Davendra Sohal, Mai Duong, Syed A. Ahmad, Namita Gandhi, Muhammad Shaalan Beg, Andrea Wang‐Gillam, James L. Wade, E. Gabriela Chiorean, Katherine A. Guthrie, Andrew M. Lowy, Philip A. Philip, Howard S. Höchster
Được phát hành 2021Artigo -
20
Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma Bằng Patrick Grierson, Benjamin Tan, Katrina S. Pedersen, Haeseong Park, Rama Suresh, Manik Amin, Nikolaos A. Trikalinos, Deborah Knoerzer, Brent Kreider, Anupama Reddy, Jingxia Liu, Channing J. Der, Andrea Wang‐Gillam, Kian‐Huat Lim
Được phát hành 2022Artigo
Công cụ tìm kiếm:
Các môn học liên quan
Medicine
Internal medicine
Cancer
Oncology
Pancreatic cancer
Chemotherapy
Gastroenterology
Colorectal cancer
Cancer research
Gemcitabine
Biology
Immunology
Irinotecan
Surgery
Fluorouracil
Adverse effect
Clinical endpoint
Pharmacology
Environmental health
Immunotherapy
Phases of clinical research
Population
Randomized controlled trial
Adenocarcinoma
Cell biology
Confidence interval
Genetics
Immune system
KRAS
MAPK/ERK pathway